SCHEMBL15365

SCHEMBL15365

COc1cc(OCc2ccccc2)ccc1F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.58
▸ ALOX5 P09917 1/20 0.53
▸ PDGFRB P09619 1/20 0.50
▸ PDGFRA P16234 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ ALOX12 P18054 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ MRGPRX4 Q96LA9 1/20 0.48
▸ LMNA P02545 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ PARP15 Q460N3 1/20 0.48
▸ PARP10 Q53GL7 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31166954 0.88 ALOX5 (0.58) MAOBALOX5MAPTSMN1; SMN2GAA
SCHEMBL27771711 0.87 MAOB (0.58) MAOBALDH1A1MAPTALOX12SMN1; SMN2
SCHEMBL18044481 0.87 MAOB (0.58) MAOBALOX5PDGFRBPDGFRAALDH1A1
SCHEMBL2090976 0.83 MAOB (0.62) MAOBALOX5PDGFRBPDGFRAALDH1A1
SCHEMBL18623122 0.83 MAOB (0.62) MAOBALOX5PDGFRBPDGFRAALDH1A1
SCHEMBL20252664 0.83 MAOB (0.57) MAOBALOX5ALDH1A1MAPTALOX12
SCHEMBL8280802 0.82 MAOB (0.60) MAOBALOX5PDGFRBPDGFRAALDH1A1
SCHEMBL16319277 0.82 MAOB (0.56) MAOBMAPTFFAR1
SCHEMBL15817 0.81 ALOX5 (0.61) MAOBALOX5MAPTSMN1; SMN2GAA
SCHEMBL1550410 0.81 MAOB (0.58) MAOBALOX5ALDH1A1MAPTALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609065-B1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE ALBEMARLE CORP (US) 2015-07-08 — — EP claimed
EP-2609065-A1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE Albemarle Corporation (US) 2013-07-03 — — EP claimed
US-20130109887-A1 PROCESSES FOR PRODUCING 1-BROMO-2- (CYCLOPROPYL METHOXY)-5-FLUORO-4-METHOXYBENZENE ALBERMARLE CORPORATION (US) 2013-05-02 — — US claimed
WO-2012027134-A1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE ALBEMARLE CORPORATION (US) 2012-03-01 — — WO claimed
EP-2609065-B1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE ALBEMARLE CORP (US) 2015-07-08 — — EP disclosed
EP-2609065-B1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE ALBEMARLE CORP (US) 2015-07-08 — — EP disclosed
EP-2609065-A1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE Albemarle Corporation (US) 2013-07-03 — — EP disclosed
US-20130109887-A1 PROCESSES FOR PRODUCING 1-BROMO-2- (CYCLOPROPYL METHOXY)-5-FLUORO-4-METHOXYBENZENE ALBERMARLE CORPORATION (US) 2013-05-02 — — US disclosed
US-20130109887-A1 PROCESSES FOR PRODUCING 1-BROMO-2- (CYCLOPROPYL METHOXY)-5-FLUORO-4-METHOXYBENZENE ALBERMARLE CORPORATION (US) 2013-05-02 — — US disclosed
US-20130109887-A1 PROCESSES FOR PRODUCING 1-BROMO-2- (CYCLOPROPYL METHOXY)-5-FLUORO-4-METHOXYBENZENE ALBERMARLE CORPORATION (US) 2013-05-02 — — US disclosed
WO-2012027134-A1 PROCESSES FOR PRODUCING 1-BROMO-2 (CYCLOPROPYL METHOXY)-5 FLUORO-4- METHOXYBENZENE ALBEMARLE CORPORATION (US) 2012-03-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109887-A1 PROCESSES FOR PRODUCING 1-BROMO-2- (CYCLOPROPYL METHOXY)-5-FLUORO-4-METHOXYBENZENE CYP4B1, CYP4X1, CYP1B1 MAOB 30/4885ALOX5 893/4885PDGFRB 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback